Capricor Therapeutics
CAPR
#7633
Rank
โ‚ฌ0.40 B
Marketcap
6,92ย โ‚ฌ
Share price
0.80%
Change (1 day)
38.58%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -โ‚ฌ0.12 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ95.76 Million a decrease over its 2024 earnings that were of -โ‚ฌ36.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.12 Billion16.58%
2025 -โ‚ฌ95.76 Million159.57%
2024 -โ‚ฌ36.89 Million81.57%
2023 -โ‚ฌ20.32 Million-23.2%
2022 -โ‚ฌ26.46 Million44.93%
2021 -โ‚ฌ18.26 Million46.61%
2020 -โ‚ฌ12.45 Million78.71%
2019 -โ‚ฌ6.97 Million-49.7%
2018 -โ‚ฌ13.85 Million-724.78%
2017 โ‚ฌ2.21 M-112.93%
2016 -โ‚ฌ17.15 Million46.27%
2015 -โ‚ฌ11.73 Million106.82%
2014 -โ‚ฌ5.67 Million-48.41%
2013 -โ‚ฌ10.99 Million977.23%
2012 -โ‚ฌ1.02 Million-77.11%
2011 -โ‚ฌ4.46 Million-22.35%
2010 -โ‚ฌ5.74 Million-20.17%
2009 -โ‚ฌ7.19 Million-41.17%
2008 -โ‚ฌ12.22 Million41.05%
2007 -โ‚ฌ8.67 Million1098.87%
2006 -โ‚ฌ0.73 Million4101.55%
2005 -โ‚ฌ0.02 Million-0.97%
2004 -โ‚ฌ0.02 Million17.87%
2003 -โ‚ฌ0.02 Million3.66%
2002 -โ‚ฌ0.02 Million-30.11%
2001 -โ‚ฌ0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B-14,566.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.78 B-766.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.71 Billion 501.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.3 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ7.64 Million-93.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ15.06 Million-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA